Using human-derived neurons in a dish, researchers found that high concentrations of THC (10 micromolar) significantly reduced neuronal function and synaptic activity during dopaminergic development, while low concentrations (1 micromolar) had minimal effects.
Readers concerned about cannabis effects on adolescent brain development.
High-dose THC significantly reduced ion currents and synaptic activity in developing human neurons
What the researchers found
Researchers used human induced pluripotent stem cells (iPSCs) to grow neurons and studied how cannabinoids affected their development into dopamine-producing cells.
At high concentrations (10 micromolar), both the endogenous cannabinoid anandamide (AEA) and THC significantly decreased neuronal functionality, indicated by reduced ion currents and synaptic activity. This suggests neurotoxic effects at high exposure levels during neurogenesis.
At low concentration (1 micromolar), THC had no marked effect on neuronal or dopaminergic maturation. Interestingly, low-dose anandamide actually enhanced synaptic activity frequency, suggesting the endocannabinoid system normally supports neuronal development at physiological levels but becomes harmful at supraphysiological concentrations.
DNA methylation in gene promotor regions important for neuronal function was not significantly affected, indicating the cannabinoid effects were not mediated through this epigenetic mechanism.
Why it matters
This study uses human-derived neurons rather than animal models to study THC's effects on brain development, making the findings more directly relevant to human biology. The concentration-dependent results suggest a threshold below which THC may have minimal developmental impact and above which significant disruption occurs.
The numbers in context
Concentrations tested: 1 and 10 micromolar. 10 micromolar AEA and THC: significantly decreased neuronal functionality. 1 micromolar THC: no marked effects. 1 micromolar AEA: enhanced synaptic activity frequency. No significant DNA methylation changes at any concentration.
How the study worked
Human cord blood-derived iPSCs were differentiated into neural precursor cells and then into mature neurons. Cultures were exposed to anandamide or THC at 1 or 10 micromolar during dopaminergic differentiation. Neuronal function was assessed by electrophysiology (ion currents and synaptic activity). DNA methylation was analyzed in relevant gene promotor regions.
What this study cannot tell us
In vitro study: neurons in a dish do not fully replicate the complexity of brain development in a living organism. The concentrations used may not directly correspond to THC levels in the developing human brain after cannabis use. iPSC-derived neurons may not perfectly recapitulate native neuronal development. Only two concentrations were tested.
How to read the evidence
Preliminary evidence from an in vitro study using human-derived neurons.
When this study was published
Published in 2017. Uses human iPSC technology to model brain development.
The bigger picture
Cannabis use during adolescence, when the brain is still developing, is a major public health concern. This study adds mechanistic detail: at high concentrations, THC disrupts the functional maturation of human neurons, particularly those becoming dopamine-producing cells. The dopaminergic system is central to reward, motivation, and executive function, making its disruption during development potentially significant for long-term cognitive outcomes.
Questions still open
- What THC concentrations actually reach the developing human brain during cannabis use? Is the threshold for neurotoxic effects consistent across different neuron types? Would chronic low-dose exposure produce cumulative effects that acute exposure does not?
Common questions
Does this prove cannabis damages the developing brain?
Were low doses of THC safe for developing neurons?
Read the original research
Functional effects of cannabinoids during dopaminergic specification of human neural precursors derived from induced pluripotent stem cells.
Addiction biology, 22(5), 1329-1342
Citation
Stanslowsky, Nancy; Jahn, Kirsten; Venneri, Anna; Naujock, Maximilian; Haase, Alexandra; Martin, Ulrich; Frieling, Helge; Wegner, Florian. (2017). Functional effects of cannabinoids during dopaminergic specification of human neural precursors derived from induced pluripotent stem cells.. Addiction biology, 22(5), 1329-1342. https://doi.org/10.1111/adb.12394
Explore the wider topic
- How THC Affects Your Amygdala: The Brain's Threat Detector and Cannabis
- The Anandamide Connection: Your Body's Natural Bliss Molecule
- How Long for Cannabinoid Receptors to Return to Normal
- Cannabis and the Developing Brain: What Every Teenager (and Parent) Should Know
- Why Can't I Enjoy Anything Without Weed? The Science Behind It
- Dopamine Recovery After Quitting Weed: What the Science Says
- The Endocannabinoid System Explained Simply: What It Does and Why It Matters
- Your Endocannabinoid System Explained: Why Withdrawal Happens
- Your Nervous System After Quitting Weed: Fight or Flight
- Using Weed Under 18: What It Does to Your Developing Brain
- What THC Does to Your Brain: Why Withdrawal Happens
- THC and Your Prefrontal Cortex: What Cannabis Does to Your Decision-Making Brain
- Weed, Cortisol, and Stress: What Cannabis Does to Your Stress Hormones
- Weed and Memory: What the Science Says About THC and Your Hippocampus
- Weed and Motivation: Is Amotivational Syndrome Real?
- Weed and Your Nervous System: What THC Actually Does to Your Brain and Body
- How Weed Rewires Your Reward System (And How to Reset It)